Evaluation of vaccines to prevent childhood pneumonia: Lessons relevant to planning tuberculosis vaccine trials

Clinical Infectious Diseases

Volumn 30, Issue SUPPL. 3, 2000, Pages

  Mulholland, K ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

BACTERIAL PNEUMONIA; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; LUNG TUBERCULOSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL VACCINES; BCG VACCINE; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS, PULMONARY;

EID: 0034465549     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313863     Document Type: Conference Paper

References (11)

1. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries
2. The aetiology of pneumonia in malnourished and well nourished Gambian children
3. Etiology of severe pneumonia in children in developing countries
4. Randomized trial of Haemophilus influenzae type b-tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants
5. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitis outer-membrane protein complex
6. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease
7. Epidemiology of acute lower respiratory tract infections, especially those due to Haemophilus influenzae type b, in the Gambia, West Africa
8. Protective efficacy of pneumococcal polysaccharide vaccines
9. Protective efficacy of BCG against tuberculous meningitis and miliary tuberculosis: A meta-analysis
10. Variation in protection by BCG: Implications of and for heterologous immunity
11. Randomized controlled trial of single BCG repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for the prevention of leprosy and tuberculosis in Malawi